| Primary |
| Rheumatoid Arthritis |
24.0% |
| Ankylosing Spondylitis |
14.3% |
| Crohn's Disease |
8.4% |
| Psoriatic Arthropathy |
7.1% |
| Musculoskeletal Pain |
5.2% |
| Arthralgia |
4.5% |
| Hypothyroidism |
3.9% |
| Spondylitis |
3.9% |
| Colitis |
3.2% |
| Pain |
3.2% |
| Back Pain |
2.6% |
| Bone Pain |
2.6% |
| Enterocolitis Haemorrhagic |
2.6% |
| Spondyloarthropathy |
2.6% |
| Arthritis |
1.9% |
| Arthritis Reactive |
1.9% |
| Essential Hypertension |
1.9% |
| Fibromyalgia |
1.9% |
| Hypertension |
1.9% |
| Myalgia |
1.9% |
|
| Pyrexia |
9.5% |
| Neutropenia |
7.9% |
| Visual Acuity Reduced |
7.9% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
6.3% |
| Rash |
6.3% |
| Drug Exposure During Pregnancy |
4.8% |
| Generalised Oedema |
4.8% |
| Rash Erythematous |
4.8% |
| Rash Maculo-papular |
4.8% |
| Renal Failure Acute |
4.8% |
| Salmonellosis |
4.8% |
| Toxic Skin Eruption |
4.8% |
| Vomiting |
4.8% |
| Weight Decreased |
4.8% |
| Asthma |
3.2% |
| Cholestasis |
3.2% |
| Extrasystoles |
3.2% |
| Haemorrhage |
3.2% |
| Interstitial Lung Disease |
3.2% |
| Meningitis Aseptic |
3.2% |
|
| Secondary |
| Ankylosing Spondylitis |
27.5% |
| Rheumatoid Arthritis |
14.3% |
| Crohn's Disease |
11.1% |
| Product Used For Unknown Indication |
7.7% |
| Polyarthritis |
7.3% |
| Drug Use For Unknown Indication |
5.2% |
| Obesity |
3.5% |
| Osteomyelitis Chronic |
3.5% |
| Hypertension |
3.1% |
| Musculoskeletal Pain |
2.8% |
| Bronchitis |
1.4% |
| Contraception |
1.4% |
| Drug Exposure During Pregnancy |
1.4% |
| Essential Hypertension |
1.4% |
| Fibromyalgia |
1.4% |
| Immune System Disorder |
1.4% |
| Inflammatory Bowel Disease |
1.4% |
| Osteoporosis |
1.4% |
| Rheumatic Disorder |
1.4% |
| Sigmoiditis |
1.4% |
|
| Pyrexia |
17.5% |
| Vomiting |
13.8% |
| Sarcoidosis |
8.8% |
| Drug Reaction With Eosinophilia And Systemic Symptoms |
5.0% |
| Genital Rash |
5.0% |
| Neutropenia |
5.0% |
| Rash Erythematous |
5.0% |
| Rash Maculo-papular |
5.0% |
| Skin Reaction |
3.8% |
| Thrombocytopenia |
3.8% |
| Visual Acuity Reduced |
3.8% |
| White Blood Cell Count Abnormal |
3.8% |
| Chronic Myeloid Leukaemia |
2.5% |
| Colitis |
2.5% |
| Cytolytic Hepatitis |
2.5% |
| Drug Exposure During Pregnancy |
2.5% |
| Drug Hypersensitivity |
2.5% |
| Haemorrhage |
2.5% |
| Human Herpesvirus 6 Infection |
2.5% |
| Lichen Planus |
2.5% |
|
| Concomitant |
| Rheumatoid Arthritis |
29.2% |
| Crohn's Disease |
14.8% |
| Drug Use For Unknown Indication |
14.2% |
| Ankylosing Spondylitis |
13.9% |
| Product Used For Unknown Indication |
9.2% |
| Hypertension |
3.0% |
| Depression |
1.9% |
| Pain |
1.9% |
| Osteoporosis |
1.6% |
| Colitis Ulcerative |
1.1% |
| Psoriasis |
1.1% |
| Arthritis |
1.0% |
| Psoriatic Arthropathy |
1.0% |
| Chronic Obstructive Pulmonary Disease |
0.9% |
| Hypothyroidism |
0.9% |
| Vitamin Supplementation |
0.9% |
| Constipation |
0.8% |
| Mineral Supplementation |
0.8% |
| Prophylaxis Against Gastrointestinal Ulcer |
0.8% |
| Bipolar Disorder |
0.7% |
|
| Cerebral Infarction |
11.8% |
| Myocardial Infarction |
11.8% |
| Abortion Spontaneous |
5.9% |
| Colon Cancer |
5.9% |
| Enterocolitis Infectious |
5.9% |
| Pustular Psoriasis |
5.9% |
| Splenic Infarction |
5.9% |
| Musculoskeletal Pain |
4.4% |
| Pulmonary Tuberculosis |
4.4% |
| Pyrexia |
4.4% |
| Thrombocytopenia |
4.4% |
| Toxic Skin Eruption |
4.4% |
| Urinary Tract Infection |
4.4% |
| Coronary Artery Disease |
2.9% |
| Epistaxis |
2.9% |
| Erectile Dysfunction |
2.9% |
| Fibroma |
2.9% |
| Hypersensitivity |
2.9% |
| Lung Adenocarcinoma Stage Iii |
2.9% |
| Lung Infection |
2.9% |
|
| Interacting |
|
|
